Skip to main content

Day: October 3, 2022

Slide Stainer Market worth $5.9 billion in 2027 – Exclusive Report by MarketsandMarkets™

Chicago, Oct. 03, 2022 (GLOBE NEWSWIRE) — Slide Stainer Market is projected to grow from USD 4.3 billion in 2022 to USD 5.9 billion by 2027, at a CAGR of 6.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. Growth in this market can be attributed to the expanding population of geriatric patients, increasing research investments into cancer and cancer drugs, the high volume of cancer biopsies, and the high prevalence of cancer, chronic diseases and infections. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412 Browse in-depth TOC on “Slide Stainer Market”194 – Tables45 – Figures226 – Pages In 2021, reagents & kits accounted for the largest share of the slide stainer market, by product. By product, the slide stainer market is segmented into reagents, equipment, and consumables...

Continue reading

Green Technology and Sustainability Market Worth $36.6 Billion By 2025 – Report by MarketsandMarkets™

Chicago, Oct. 03, 2022 (GLOBE NEWSWIRE) — Green Technology and Sustainability Market size to grow from USD 11.2 billion in 2020 to USD 36.6 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 26.6% during the forecast period, according to a new report by MarketsandMarkets™. Modernization of IT and telecom infrastructure for low carbon emission will provide huge opportunities in the market. The increasing awareness related to environmental concerns and the growing consumer and industrial interest for the use of clean energy resources are driving the adoption of green technology and sustainability solutions and services in the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=224421448 Browse in-depth TOC on “Green Technology and Sustainability Market”189 – Tables36 –...

Continue reading

Achiko AG Reports First Half to June 30, 2022 Results and Provides Corporate Update as of September 30, 2022

Achiko reports an EBITDA loss of USD $1.9 million, compared to an EBITDA loss of USD $4.6 million for the six months ending June 30, 2021. Focal points of the first half year were completion of a major new sales contract in Indonesia, obtaining a CE Mark for AptameX™ and streamlining the organization ahead of launching and scaling production for sales to Indonesia and other countries. AptameX™, Achiko’s proprietary low-cost, saliva-based Covid-19 diagnostic, has shown competitive product performance to other Covid-19 testing solutions with calibration testing confirming its ability to deliver a >97% sensitive and >97% specific rapid test at a wider range of viral loads than most other rapid tests. After the balance sheet date, raised CHF 1.25 million in financing with sophisticated investors.ZURICH, Switzerland, Oct. 03, 2022 (GLOBE...

Continue reading

Identify the Touch Sensor Market Growth Opportunities by 2027 – Exclusive Report by MarketsandMarkets™

Chicago, Oct. 03, 2022 (GLOBE NEWSWIRE) — Touch Sensor Market by Technology, Product, Application and Region – Global Forecast to 2027. A touch sensor, also known as tactile sensors is an electronic sensor used to detect and record physical touch. These sensors are economical miniature-sized alternatives to traditional mechanical switches. They are widely used for smartphones, displays, robotics, automotive, smart homes, and industrial applications. The increasing usage of touch sensors in portable electronics devices such as smartphones, smart TVs, and tablets and the growing demand for interactive digital signage in retail stores and malls are the key factors boosting the growth of the market. Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214445362 Drivers: Increase in use of touch sensors...

Continue reading

Venus Concept Announces Appointment of Rajiv De Silva as Chief Executive Officer and Director; Updates Fiscal Year 2022 Revenue Guidance

TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that Rajiv De Silva has been appointed as the Company’s Chief Executive Officer and a member of the Board of Directors (the “Board”), effective October 2, 2022. The Company also announced the separation of Domenic Serafino as Chief Executive Officer and Director, effective October 2, 2022. This separation was not the result of any specific disagreement about strategy with management or the Board, inappropriate action, violation of company policy or any accounting irregularity. Mr. De Silva currently serves as the Chairman of Covis Pharma, a privately-held, multinational specialty pharmaceutical company, and is a co-founder of Asiri Skincare, a privately-held...

Continue reading

BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data at HFSA Annual Meeting

Clinical Leadership and Management Call Scheduled for Wednesday, October 5, 2022, at 8:55am Eastern Time SUNNYVALE, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces data from its FDA designated Breakthrough CardiAMP® Cell Therapy for Heart Failure pivotal trial (ClinicalTrials.gov Identifier: NCT02438306) presented at the Heart Failure Society of America meeting in Washington, D.C.. Peter Johnston, M.D., Assistant Professor of Medicine and Site Principal Investigator at Johns Hopkins University, presented the data, titled “Autologous Cell Therapy for HFrEF: Efficacy Outcomes at Two Years for the Roll-in Cohort of a Phase III Pivotal Trial.”    “The two-year outcomes for patients...

Continue reading

Tonix Pharmaceuticals Announces IND Clearance for TNX-601 ER as a Potential Treatment for Major Depressive Disorder

TNX-601 ER, Tianeptine Hemioxalate, is an Extended-Release Tablet for Once-a-Day Dosing Phase 2 Clinical Trial of TNX-601 ER Expected to Start First Quarter 2023 CHATHAM, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) —  Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to support a Phase 2 clinical trial with TNX-601 ER (tianeptine hemioxalate extended-release tablets), a once-daily formulation of tianeptine as a potential treatment for major depressive disorder (MDD)1. Tianeptine is a new molecular entity in the U.S. that is being developed under the 505(b)(1) pathway. Tianeptine sodium (amorphous) immediate release (IR) tablets have been available in...

Continue reading

Xos Delivers 65 Vehicles to Merchants Fleet in Q3 2022

Stepvans deployed to two California-based cities for the returning customer LOS ANGELES, Oct. 03, 2022 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS), a leading technology company that provides fleet services, software solutions, and manufactures Class 5 through Class 8 battery-electric commercial vehicles, today announced it has delivered 65 of its 100% battery-electric stepvan to return customer Merchants Fleet. The vehicles have been split between Antioch in Northern California and Alhambra in Southern California. This brings the total number of Xos stepvans delivered to Merchants Fleet to 123. “Merchants Fleet has continued to push the envelope in fleet electrification and serves as a role model for the industry,” said Jessica Savage, Head of Distribution at Xos. “We’ve enjoyed partnering with them over the past several years to...

Continue reading

Brunswick Exploration Options Lithium-Bearing Pegmatite in Ontario

MONTREAL, Oct. 03, 2022 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (“BRW” or the “Company”) is pleased to announce that it has staked multiple claim groups near Hearst Ontario, totaling 60 claims and 26,318 hectares in an area that is highly prospective for lithium pegmatites. The company has also optioned a spodumene-bearing pegmatite adjacent to the new project (Decoy and Moskito pegmatites) that contains up to 5.15% Li2O in historical chip samples. The entire Hearst portfolio includes 226 claims and covers 29,805 hectares. Mr. Killian Charles, President of BRW, commented: “We are pleased to announce our first acquisition in Ontario that adds to our significant portfolio of properties in Quebec and the Atlantic provinces. Ontario is also very prospective for lithium exploration and we believe the Hearst area is a fantastic...

Continue reading

Consolidated Uranium Completes the Acquisition of the Ben Lomond Uranium Project in Queensland, Australia

TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (“CUR”, the “Company”, “Consolidated Uranium”) (TSXV: CUR) (OTCQB: CURUF) is pleased to provide the following update on the option agreement with Mega Uranium Ltd. (“Mega”) (TSX: MGA) that was previously announced on May 14, 2020, as amended (the “Option Agreement”), providing CUR with the option to acquire a 100% undivided interest in the Ben Lomond and Georgetown uranium projects in Australia. CUR has completed the acquisition of the Ben Lomond project for consideration comprised of $2,500,000 in connection with the exercise of the option and an additional $535,000 in connection with the spot price contingent payment terms of the Option Agreement. The total amount of $3,035,000 was satisfied by the issuance of 1,340,548 common shares of CUR (“Common Shares”),...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.